Concepedia

Author

Dimosthenis Skarlos

Hospital Agioi Anargyroi

Also Known As

D Skarlos, D V Skarlos, D Vasilios Skarlos, D. Skarlos, D. V. Skarlos, D.V. Skarlos, Dimosthenis Skarlos, Dimosthenis V Skarlos, Dimosthenis V. Skarlos, Dimosthenis Vasilios Skarlos

136

Publications

10.8K

Citations

40

H-Index

55

Concepts

All Affiliations

Hospital Agioi AnargyroiAristotle University of ThessalonikiUniversity Hospital of IoanninaNational and Kapodistrian University of AthensHenry Dunant Hospital
DS

About

Dimosthenis Skarlos is an author at Hospital Agioi Anargyroi specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

53

3.5K

2

Health Sciences

6

6

426

3

Cell Biology

2

2

209

4

Engineering

1

1

92

5

Biomedical Engineering

1

1

92

Dimosthenis Skarlos

×

88

Publications

9.6K

Citations

38

H-Index

YearCitations

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Charles E. Geyer, John Forster, Deborah Lindquist,

New England Journal of Medicine

2006

3.4K

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

David Cameron, Michelle Casey, Michael F. Press,

Breast Cancer Research and Treatment

2008

801

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda,

Journal of Clinical Oncology

1999

506

Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study

Sanjiv S. Agarwala, John M. Kirkwood, Martin Gore,

Journal of Clinical Oncology

2004

356

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides,

Journal of Clinical Oncology

2002

255

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

C. Christodoulou, A. Pervena, G. Klouvas,

Oncology

2009

234

Advanced stage mucinous epithelial ovarian cancer: The Hellenic Cooperative Oncology Group experience

Dimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos,

Gynecologic Oncology

2005

211

Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study

Evangelos Briasoulis, D. Bafaloukos, E. Samantas,

Journal of Clinical Oncology

2000

203

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Evangelia Razis, Mattheos Bobos, Vassiliki Kotoula,

Breast Cancer Research and Treatment

2011

176

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

C. Christodoulou, Dimitrios Bafaloukos, P. Kosmidis,

Annals of Oncology

2001

175

Page 1